ARS Pharmaceuticals, Inc. (SPRY): Targeting Life-Threatening Allergies

Neffy’s needle-free delivery system offers a major advantage for patients who fear needles or face difficulty using injectable devices during emergencies.

ARS Pharmaceuticals, Inc. (SPRY)

ARS Pharmaceuticals, Inc. focuses on developing treatments for severe allergic reactions, particularly anaphylaxis. The company’s lead product, Neffy, is a needle-free epinephrine nasal spray designed to treat life-threatening allergic emergencies. This innovative approach aims to make emergency treatment more accessible,…